Issue navigation
Volume 7, Issue 1, January-December 2025
Review
Presentation, management, and outcomes of central nervous system metastases in Africa: Systematic review and meta-analysis
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae219, https://doi.org/10.1093/noajnl/vdae219
Therapeutic manipulation and bypass of the blood–brain barrier: powerful tools in glioma treatment
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae201, https://doi.org/10.1093/noajnl/vdae201
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae228, https://doi.org/10.1093/noajnl/vdae228
Radiotherapy and radiosurgery for intracranial lesions in Africa: Insights from 3 country case studies: A systematic review
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf013, https://doi.org/10.1093/noajnl/vdaf013
Emerging mechanism and therapeutic potential of neurofibromatosis type 1-related nerve system tumor: Advancing insights into tumor development
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf040, https://doi.org/10.1093/noajnl/vdaf040
Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf049, https://doi.org/10.1093/noajnl/vdaf049
Brief Communication
Venous thromboembolism incidence shortens survival in isocitrate dehydrogenase wild-type glioblastoma
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf018, https://doi.org/10.1093/noajnl/vdaf018
Location and extent of disease predicts outcome of neurofibromatosis type 1-related pediatric low-grade gliomas
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf050, https://doi.org/10.1093/noajnl/vdaf050
Basic and Translational Investigations
Pediatric brain tumor classification using deep learning on MR images with age fusion
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae205, https://doi.org/10.1093/noajnl/vdae205
The potential of GPT-4 advanced data analysis for radiomics-based machine learning models
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae230, https://doi.org/10.1093/noajnl/vdae230
Multi-center real-world data-driven web calculator for predicting outcomes in IDH-mutant gliomas: Integrating molecular subtypes and treatment modalities
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae221, https://doi.org/10.1093/noajnl/vdae221
AI-guided virtual biopsy: Automated differentiation of cerebral gliomas from other benign and malignant MRI findings using deep learning
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae225, https://doi.org/10.1093/noajnl/vdae225
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae185, https://doi.org/10.1093/noajnl/vdae185
Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypes
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae215, https://doi.org/10.1093/noajnl/vdae215
Sonic hedgehog medulloblastoma cells in co-culture with cerebellar organoids converge towards in vivo malignant cell states
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae218, https://doi.org/10.1093/noajnl/vdae218
Cuproplasia-related gene signature: Prognostic insights for glioma therapy
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae233, https://doi.org/10.1093/noajnl/vdae233
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf010, https://doi.org/10.1093/noajnl/vdaf010
Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligands
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae229, https://doi.org/10.1093/noajnl/vdae229
The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf015, https://doi.org/10.1093/noajnl/vdaf015
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf024, https://doi.org/10.1093/noajnl/vdaf024
Synthetic O-(2-18F-fluoroethyl)-l-tyrosine-positron emission tomography generation and hotspot prediction via preoperative MRI fusion of gliomas lacking radiographic high-grade characteristics
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf001, https://doi.org/10.1093/noajnl/vdaf001
Heterogeneity of intracellular calcium signaling of glioblastoma cells depends on intratumoral location and migration state
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf055, https://doi.org/10.1093/noajnl/vdaf055
Inferred developmental origins of brain tumors from single-cell RNA-sequencing data
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf016, https://doi.org/10.1093/noajnl/vdaf016
Clinical Investigations
Abdominal myosteatosis measured with computed tomography predicts poor outcomes in patients with glioblastoma
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae209, https://doi.org/10.1093/noajnl/vdae209
A phase Ib study evaluating the c-MET inhibitor INC280 (capmatinib) in combination with bevacizumab in patients with high-grade glioma
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae220, https://doi.org/10.1093/noajnl/vdae220
Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae224, https://doi.org/10.1093/noajnl/vdae224
The value of AI for assessing longitudinal brain metastases treatment response
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae216, https://doi.org/10.1093/noajnl/vdae216
High-dose MTX-based polychemotherapy for primary CNS lymphoma in younger patients: Long-term efficacy of the modified Bonn protocol
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf005, https://doi.org/10.1093/noajnl/vdaf005
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2–4: Tolerability, predictors of response, and outcomes
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae227, https://doi.org/10.1093/noajnl/vdae227
A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf011, https://doi.org/10.1093/noajnl/vdaf011
Real-world analysis of treatment patterns and survival outcome of glioblastoma patients in a German single-center study: Can survival rates of randomized controlled trials be achieved?
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf009, https://doi.org/10.1093/noajnl/vdaf009
A multi-institutional retrospective cohort of adult-onset medulloblastoma in the modern era
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae231, https://doi.org/10.1093/noajnl/vdae231
Fractionated reirradiation of recurrent high-grade gliomas: Safety with higher reirradiation dose and larger targets
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf004, https://doi.org/10.1093/noajnl/vdaf004
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf002, https://doi.org/10.1093/noajnl/vdaf002
Rise in post-resection neutrophil-to-lymphocyte ratio correlates with decreased survival in glioblastoma patients
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf014, https://doi.org/10.1093/noajnl/vdaf014
Carboplatin and vinblastine monthly in the optic pathway and hypothalamic gliomas: A retrospective analysis in a single institute
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf020, https://doi.org/10.1093/noajnl/vdaf020
A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf022, https://doi.org/10.1093/noajnl/vdaf022
Size matters: Early progression of melanoma brain metastases after treatment with immune checkpoint inhibitors
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf026, https://doi.org/10.1093/noajnl/vdaf026
Distant brain failure after stereotactic radiosurgery for brain metastases in patients receiving novel systemic treatments
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf027, https://doi.org/10.1093/noajnl/vdaf027
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)-l-tyrosine PET
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf023, https://doi.org/10.1093/noajnl/vdaf023
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf033, https://doi.org/10.1093/noajnl/vdaf033
Current trends in the allocation of National Institute of Health funding of brain tumor research
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae203, https://doi.org/10.1093/noajnl/vdae203
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf041, https://doi.org/10.1093/noajnl/vdaf041
Outcomes in patients with multiple sclerosis and solid organ cancers treated with immune checkpoint inhibitors
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf048, https://doi.org/10.1093/noajnl/vdaf048
Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastoma
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf038, https://doi.org/10.1093/noajnl/vdaf038
Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf054, https://doi.org/10.1093/noajnl/vdaf054
New-onset facial spasm is associated with treatment failure after radiosurgery in vestibular schwannoma
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf021, https://doi.org/10.1093/noajnl/vdaf021
Sex-specific difference in treatment success/failure after vestibular schwannoma treatment
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf025, https://doi.org/10.1093/noajnl/vdaf025
Meta-analysis/Systematic Review
Neuroimaging of postoperative pediatric cerebellar mutism syndrome: a systematic review
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae212, https://doi.org/10.1093/noajnl/vdae212
Post-intrathecal chemotherapy-related paraplegia syndrome in hematological cancer patients: A systematic review
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae217, https://doi.org/10.1093/noajnl/vdae217
Exploring adult glioma through MRI: A review of publicly available datasets to guide efficient image analysis
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae197, https://doi.org/10.1093/noajnl/vdae197
Risk analysis of radiosurgery for vestibular schwannoma: Systematic review and comparative study of 10-year outcomes
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae191, https://doi.org/10.1093/noajnl/vdae191
Mapping glioma’s impact on cognition: Insights from macrostructure, microstructure, and beyond
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf003, https://doi.org/10.1093/noajnl/vdaf003
Erratum
Erratum to: Evolutionary evidence precludes ELP1 as a high-penetrance pediatric cancer predisposition syndrome gene
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae213, https://doi.org/10.1093/noajnl/vdae213
